SV2006002070A - Nueva forma cristalina de acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo[4,3,0]nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-3-quinolincarboxilico ref. bhc031064-sv - Google Patents

Nueva forma cristalina de acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo[4,3,0]nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-3-quinolincarboxilico ref. bhc031064-sv

Info

Publication number
SV2006002070A
SV2006002070A SV2005002070A SV2005002070A SV2006002070A SV 2006002070 A SV2006002070 A SV 2006002070A SV 2005002070 A SV2005002070 A SV 2005002070A SV 2005002070 A SV2005002070 A SV 2005002070A SV 2006002070 A SV2006002070 A SV 2006002070A
Authority
SV
El Salvador
Prior art keywords
quinolincarboxilico
bhc031064
ciclopropil
diazabiciclo
dihidro
Prior art date
Application number
SV2005002070A
Other languages
English (en)
Inventor
Dr Hubert Rast
Iris Heep
Alfons Grunenberg
Dr Jordi Benet Buchholz
Werner Hallenbach
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of SV2006002070A publication Critical patent/SV2006002070A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

LA PRESENTE INVENCION SE REFIERE AL TRIHIDRATO DE PRADOFLOXACINO, A PROCEDIMIENTOS PARA SU PREPARACION ASI COMO AGENTES ANTIBACTERIANOS QUE CONTIENEN ESTE
SV2005002070A 2004-04-01 2005-04-01 Nueva forma cristalina de acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo[4,3,0]nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-3-quinolincarboxilico ref. bhc031064-sv SV2006002070A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004015981A DE102004015981A1 (de) 2004-04-01 2004-04-01 Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure

Publications (1)

Publication Number Publication Date
SV2006002070A true SV2006002070A (es) 2006-03-15

Family

ID=34962324

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002070A SV2006002070A (es) 2004-04-01 2005-04-01 Nueva forma cristalina de acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo[4,3,0]nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-3-quinolincarboxilico ref. bhc031064-sv

Country Status (32)

Country Link
US (1) US7977484B2 (es)
EP (1) EP1737859B1 (es)
JP (1) JP5190259B2 (es)
KR (1) KR101217678B1 (es)
CN (1) CN100591681C (es)
AR (2) AR048099A1 (es)
AT (1) ATE450536T1 (es)
AU (1) AU2005231918B2 (es)
BR (1) BRPI0509529B8 (es)
CA (1) CA2561635C (es)
CY (2) CY1109762T1 (es)
DE (3) DE102004015981A1 (es)
DK (1) DK1737859T3 (es)
ES (1) ES2335899T3 (es)
GT (1) GT200500043A (es)
HK (1) HK1104537A1 (es)
HR (1) HRP20100097T1 (es)
IL (1) IL178353A (es)
MY (1) MY140998A (es)
NO (1) NO337279B1 (es)
NZ (1) NZ550226A (es)
PE (1) PE20060170A1 (es)
PL (1) PL1737859T3 (es)
PT (1) PT1737859E (es)
RU (1) RU2383543C2 (es)
SI (1) SI1737859T1 (es)
SV (1) SV2006002070A (es)
TW (1) TWI350755B (es)
UA (1) UA84329C2 (es)
UY (1) UY28828A1 (es)
WO (1) WO2005097789A1 (es)
ZA (1) ZA200608072B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
PE20191462A1 (es) 2017-02-13 2019-10-16 Bayer Animal Health Gmbh Composicion liquida que contiene pradofloxacina
CN115710267A (zh) * 2022-11-30 2023-02-24 天津大学 一种普拉沙星水合物晶体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9707606B1 (pt) 1996-02-23 2010-08-10 ácidos 8-ciano-1-ciclopropil-7-(2,8-diazabiciclo(4.3.0) nonan-8-il)-6-flúor-1,4-diidro-4-oxo-3-quinolinocarbo xìlicos, bem como medicamentos que os compreendem.
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
BRPI0509529A (pt) 2007-09-18
KR101217678B1 (ko) 2013-01-02
US20080125458A1 (en) 2008-05-29
AR105177A2 (es) 2017-09-13
US7977484B2 (en) 2011-07-12
ATE450536T1 (de) 2009-12-15
CY1109762T1 (el) 2014-09-10
DE502005008620D1 (de) 2010-01-14
ZA200608072B (en) 2008-01-08
JP5190259B2 (ja) 2013-04-24
ES2335899T3 (es) 2010-04-06
CN1938304A (zh) 2007-03-28
TW200602053A (en) 2006-01-16
HK1104537A1 (en) 2008-01-18
CN100591681C (zh) 2010-02-24
PT1737859E (pt) 2010-02-03
AU2005231918B2 (en) 2011-05-12
BRPI0509529B8 (pt) 2021-05-25
RU2006138362A (ru) 2008-05-10
DE122011100055I1 (de) 2012-03-15
EP1737859B1 (de) 2009-12-02
IL178353A (en) 2011-08-31
AU2005231918A1 (en) 2005-10-20
HRP20100097T1 (hr) 2010-04-30
TWI350755B (en) 2011-10-21
NZ550226A (en) 2009-11-27
NO337279B1 (no) 2016-02-29
CA2561635A1 (en) 2005-10-20
DE102004015981A1 (de) 2005-10-20
AR048099A1 (es) 2006-03-29
DK1737859T3 (da) 2010-04-06
BRPI0509529B1 (pt) 2019-05-21
GT200500043A (es) 2006-02-17
UY28828A1 (es) 2005-11-30
NO20064988L (no) 2006-10-31
PE20060170A1 (es) 2006-04-13
WO2005097789A1 (de) 2005-10-20
SI1737859T1 (sl) 2010-03-31
CA2561635C (en) 2012-10-16
KR20070014157A (ko) 2007-01-31
RU2383543C2 (ru) 2010-03-10
PL1737859T3 (pl) 2010-04-30
JP2007530614A (ja) 2007-11-01
MY140998A (en) 2010-02-12
CY2011018I1 (el) 2016-12-14
UA84329C2 (en) 2008-10-10
EP1737859A1 (de) 2007-01-03
IL178353A0 (en) 2007-02-11

Similar Documents

Publication Publication Date Title
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
HN2011001186A (es) Proceso para la preparacion de derivados de l-alanina protegidos
ECSP11011348A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3
GT200500103A (es) 4-fenilamino-quinazolin-6-il-amidas
BRPI0512683A (pt) compostos anti-virais
ECSP10010620A (es) Derivados de indazol sustituidos con fenilo y benzodioxinilo
CR9369A (es) Compuestos de peridil acido acetico
CL2012000768A1 (es) Compuestos derivados de acido l-glutamico y l-glutamina marcados con [18f]; procedimiento de preparacion; y su uso para el diagnostico de enfermedades tumorales.
UY29343A1 (es) Pirazolopiridinas y sales de las mismas, una composición farmacéutica que comprende dichos compuestos, un método para prepararlos y su uso.
BR112012029647A2 (pt) novos derivados de pirimidinas
CO6270226A2 (es) Nuevos compuestos espirociclicos como antagonistas de cgrp
BR122017022221B8 (pt) Processo para preparação de 2-amino-5,8-alcóxi[1,2,4]triazol[l,5-c]pirimidinas
ECSP11011346A (es) 3-Amino-2-mercaptoquinolina sustituida como modulador de KCNQ2/3
GT200500311A (es) Compuestos organicos
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
ECSP099070A (es) Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios
SV2006002070A (es) Nueva forma cristalina de acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo[4,3,0]nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-3-quinolincarboxilico ref. bhc031064-sv
CR8669A (es) Compuestos de sulfonamidas para el tratamiento de trastornos neurodegenerativos
ECSP11011345A (es) 2-mercapto-3-aminopiridina sustituida como moduladores de kcnq2/3
UY31162A1 (es) Espiroindolinas como moduladores de receptores de quimioquinas
BRPI0517390B8 (pt) processo para a preparação de derivados de [1,4,5]-oxadiazepam
ECSP067028A (es) Profármacos de esteroides con acción androgénica
MX2008011576A (es) Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
BR112014014635A2 (pt) método para fabricar um composto, e, composto